{"id":"W2992570001","doi":"10.1186/s40425-019-0559-3","title":"Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study","year":2019,"lang":"en","type":"erratum","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; University of Calgary; BC Cancer Agency","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Pazopanib; Sunitinib; Nivolumab; Renal cell carcinoma; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049614,0.002038815,0.001876845,0.002441528,0.001849692,0.003212309,0.002655082,0.006348832,0.02921839],"category_scores_gemma":[0.05241768,0.0009347902,0.001852214,0.001424354,0.001238447,0.001419778,0.000980977,0.009084038,0.01593967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003771291,"about_ca_system_score_gemma":0.004772305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01701661,"about_ca_topic_score_gemma":0.02095533,"domain_scores_codex":[0.9958554,0.0007817232,0.0009118845,0.0004663762,0.001595576,0.0003891342],"domain_scores_gemma":[0.9744125,0.006966953,0.001477859,0.0009910061,0.01456377,0.001587902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004255831,0.000006558412,0.00007580851,0.00008441861,0.00001151516,0.0001511738,0.00001089238,0.0000231582,0.00002401348,0.0001694603,0.9959826,0.00341774],"study_design_scores_gemma":[0.0002281181,0.00006183304,0.00162514,0.0008216195,0.00009247425,0.001104329,0.00006425419,0.0003982839,0.0003227447,0.0009574582,0.9942684,0.00005537484],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0001923844,0.0009712297,0.0003739558,0.0637272,0.9315496,0.00003184805,0.0009710935,0.000175481,0.002007165],"genre_scores_gemma":[0.01453725,0.007626333,0.003767116,0.1796234,0.6452239,0.0002613144,0.003016035,0.001050252,0.1448944],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.02921839,"threshold_uncertainty_score":0.09774518,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02364807024486524,"score_gpt":0.3224316510280897,"score_spread":0.2987835807832245,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}